11.01.2022 - By JAMA Network
Deciding Whether to Continue Using Teratogenic Drugs in States That Have Banned Abortions; Treating Cancer in Pregnant Patients After Roe v Wade Overturned; Dobbs Decision Threatens Full Breadth of Ob-Gyn Training Related Content: Threats to Evidence-Based Care With Teratogenic Medications in States With Abortion Restrictions Treating Cancer in Pregnant Patients After Roe v Wade Overturned Dobbs Decision Threatens Full Breadth of Ob-Gyn Training